Isodiol International Inc. Share Price

Equities

ISOLF

CA46500L2003

Pharmaceuticals

Delayed OTC Markets 14:44:26 16/05/2024 BST 5-day change 1st Jan Change
0.000001 USD -99.00% Intraday chart for Isodiol International Inc. 0.00% 0.00%
Sales 2018 19.14M 1.5B Sales 2019 22.25M 1.74B Capitalization 49.96M 3.91B
Net income 2018 -36M -2.82B Net income 2019 -126M -9.87B EV / Sales 2018 12.6 x
Net cash position 2018 15.55M 1.22B Net Debt 2019 5.22M 409M EV / Sales 2019 2.48 x
P/E ratio 2018
-4.94 x
P/E ratio 2019
-0.37 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 month
0.00
Extreme 0
0.00
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.29
5 years
0.00
Extreme 0
1.05
10 years
0.00
Extreme 0
16.90
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23/05/17
Director/Board Member - 29/08/18
Corporate Officer/Principal - 13/02/19
Members of the board TitleAgeSince
Chief Executive Officer - 23/05/17
Director/Board Member - 29/08/18
Director/Board Member - 20/11/18
More insiders
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nano-technology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
More about the company